FDA approves drug to fight high cholesterol

Health News

(CNN) – The US Food and Drug Administration has approved a new cholesterol-lowering medication.

Esperion’s Nexletol is a once-daily tablet and is an alternative for millions of patients that can’t take or don’t respond well to statins.

The company says it’s the first oral non-statin drug approved in nearly two decades.

During studies, the drug reduced cholesterol in patients by an average of 18 percent when used with moderate or high-intensity statins.

The new drug could become available as early as late March.

LATEST STORIES:

Copyright 2020 Nexstar Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Trending Stories

get the app

News App

Weather App

Don't Miss

More Don't Miss